Neurology · Medical Literature
Motor imagery-based brain-computer interface training for post-stroke upper limb dysfunction: systematic review and meta-analysis.
Abstract
Motor imagery-based brain-computer Interface (MI-BCI) utilises electroencephalographic signals from imagined limb movements for control commands, enabling real-time interaction with external devices. Clinical trials suggest its potential for upper limb recovery post-stroke. This study aims to systematically evaluate the effectiveness of MI-BCI on upper limb motor function in patients with post-stroke hemiplegia. A comprehensive search was conducted across PubMed, Cochrane Library, Web of Science and Embase through March 2026 for randomised controlled trials assessing MI-BCI effects on upper limb motor impairments post-stroke. A systematic review and meta-analysis were performed. The analysis included 27 studies for systematic review, with meta-analyses encompassing 24 studies involving 846 participants. MI-BCI training showed statistically significant improvements in measures of isolated limb movement and fine motor control, specifically the Fugl-Meyer Assessment for Upper Extremity (s.m.d. 0.31, 95% CI: 0.18-0.45; I² = 17%) and the Wolf Motor Function Test (s.m.d. 0.45, 95% CI: 0.24-0.66; I² = 39%). MI-BCI training can improve upper limb motor function, particularly for isolated movements and fine motor control, in stroke patients. Its effects on complex functional activities, activities of daily living and spasticity were not significant in the current evidence. Due to heterogeneity in control conditions (including sham interventions) across studies, the current evidence does not support definitive conclusions regarding its superiority over standardised traditional rehabilitation.
Clinical relevance
Post-stroke upper limb hemiplegia remains one of the leading causes of long-term disability, with a significant proportion of survivors failing to regain functional independence despite conventional rehabilitation. This systematic review and meta-analysis of 27 RCTs (846 participants) addresses the growing clinical interest in neurotechnology-assisted rehabilitation by rigorously evaluating whether MI-BCI—which harnesses EEG signals derived from imagined movements to drive real-time interaction with external devices—produces measurable motor recovery beyond standard care. Given the increasing availability of BCI platforms in rehabilitation settings, neurologists and physiatrists need current, high-quality evidence to guide appropriate patient selection and technology integration.
Key findings
1. MI-BCI training produced a statistically significant improvement in the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), a measure of isolated limb movement, with a standardised mean difference (SMD) of 0.31 (95% CI: 0.18–0.45; I² = 17%), indicating low heterogeneity and a small but consistent effect. 2. MI-BCI training also significantly improved fine motor control as measured by the Wolf Motor Function Test (WMFT), with an SMD of 0.45 (95% CI: 0.24–0.66; I² = 39%), representing a small-to-moderate effect size with moderate heterogeneity. 3. The meta-analysis incorporated 24 studies with 846 participants drawn from a broader systematic review of 27 RCTs, providing a reasonably powered evidence base for the primary motor outcomes assessed. 4. Effects of MI-BCI on complex functional activities and activities of daily living (ADL) did not reach statistical significance in the current pooled evidence. 5. MI-BCI demonstrated no significant effect on upper limb spasticity based on available trial data. 6. Substantial heterogeneity in control conditions across studies—including varying sham interventions and comparator therapies—precluded definitive conclusions regarding the superiority of MI-BCI over standardised traditional rehabilitation protocols.
Practice implications
MI-BCI may be selectively considered as an adjunct rehabilitation modality for post-stroke patients with upper limb hemiplegia in whom the primary goal is improvement of isolated joint movements and fine motor control (as indexed by FMA-UE and WMFT), rather than broader ADL independence or spasticity reduction, where current evidence does not support its use. Clinicians should recognise that the observed effect sizes are small-to-moderate (SMD 0.31–0.45) and that the absence of a well-defined standardised control condition across trials limits certainty of benefit over conventional therapy alone, necessitating cautious, goal-directed patient selection. Until future RCTs establish optimal training parameters (session frequency, duration, EEG paradigm, and comparator conditions), MI-BCI should complement—rather than replace—evidence-based upper limb rehabilitation programmes, with outcomes monitored using validated tools such as the FMA-UE and WMFT.